Detalhe da pesquisa
1.
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study.
Oncologist
; 25(8): e1158-e1169, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452601
2.
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer.
Invest New Drugs
; 38(5): 1400-1410, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31953695
3.
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer.
Cancer Immunol Immunother
; 66(11): 1437-1447, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28688082
4.
NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.
J Natl Compr Canc Netw
; 14(11): 1357-1370, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27799507
5.
Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer.
Support Care Cancer
; 24(7): 2913-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26847349
6.
Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic complete response in patients with early stage HER2-positive breast cancer: a meta-analysis of randomized prospective clinical trials.
Oncologist
; 20(4): 337-43, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25732265
7.
Yoga and self-reported cognitive problems in breast cancer survivors: a randomized controlled trial.
Psychooncology
; 24(8): 958-66, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336068
8.
Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.
Support Care Cancer
; 23(7): 2019-24, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25519756
9.
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.
Breast Cancer Res
; 16(2): R23, 2014 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24602188
10.
A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.
Invest New Drugs
; 32(6): 1285-94, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24894652
11.
Focal takotsubo cardiomyopathy with high-dose interleukin-2 therapy for malignant melanoma.
J Natl Compr Canc Netw
; 12(12): 1666-70; quiz 1670, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25505207
12.
Senior adult oncology, version 2.2014: clinical practice guidelines in oncology .
J Natl Compr Canc Netw
; 12(1): 82-126, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24453295
13.
Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.
Support Care Cancer
; 21(10): 2679-86, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23686402
14.
Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy.
Support Care Cancer
; 21(10): 2845-51, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23748485
15.
Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancer.
Invest New Drugs
; 29(2): 347-51, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19844661
16.
Senior adult oncology.
J Natl Compr Canc Netw
; 10(2): 162-209, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22308515
17.
Phase II study of celecoxib in metastatic differentiated thyroid carcinoma.
J Clin Endocrinol Metab
; 91(6): 2201-4, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16522694
18.
Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.
Clin Breast Cancer
; 7(2): 141-5, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16800973
19.
Survivorship and complications of treatment in breast cancer.
Clin Adv Hematol Oncol
; 3(3): 211-22, 238, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16166992
20.
Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage II or III HER2-negative breast cancer.
Clin Breast Cancer
; 14(4): 228-34, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24703985